Corvus Pharmaceuticals Inc (CRVS)
1.73
+0.12
(+7.45%)
USD |
NASDAQ |
May 02, 12:33
Corvus Pharmaceuticals Market Cap: 84.84M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 78.95M |
| April 30, 2024 | 76.01M |
| April 29, 2024 | 77.48M |
| April 26, 2024 | 71.11M |
| April 25, 2024 | 72.58M |
| April 24, 2024 | 74.05M |
| April 23, 2024 | 75.03M |
| April 22, 2024 | 70.62M |
| April 19, 2024 | 68.65M |
| April 18, 2024 | 69.14M |
| April 17, 2024 | 66.69M |
| April 16, 2024 | 72.09M |
| April 15, 2024 | 72.09M |
| April 12, 2024 | 75.03M |
| April 11, 2024 | 76.50M |
| April 10, 2024 | 74.05M |
| April 09, 2024 | 79.93M |
| April 08, 2024 | 83.86M |
| April 05, 2024 | 85.82M |
| April 04, 2024 | 82.88M |
| April 03, 2024 | 85.82M |
| April 02, 2024 | 91.21M |
| April 01, 2024 | 91.21M |
| March 28, 2024 | 87.29M |
| March 27, 2024 | 87.78M |
| Date | Value |
|---|---|
| March 26, 2024 | 86.31M |
| March 25, 2024 | 86.31M |
| March 22, 2024 | 87.78M |
| March 21, 2024 | 90.23M |
| March 20, 2024 | 90.72M |
| March 19, 2024 | 96.12M |
| March 18, 2024 | 93.17M |
| March 15, 2024 | 93.17M |
| March 14, 2024 | 92.19M |
| March 13, 2024 | 98.08M |
| March 12, 2024 | 99.06M |
| March 11, 2024 | 98.57M |
| March 08, 2024 | 103.96M |
| March 07, 2024 | 111.81M |
| March 06, 2024 | 105.43M |
| March 05, 2024 | 103.47M |
| March 04, 2024 | 105.92M |
| March 01, 2024 | 106.90M |
| February 29, 2024 | 109.85M |
| February 28, 2024 | 112.79M |
| February 27, 2024 | 115.73M |
| February 26, 2024 | 112.79M |
| February 23, 2024 | 115.24M |
| February 22, 2024 | 113.28M |
| February 21, 2024 | 112.79M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
30.18M
Minimum
Mar 28 2023
361.85M
Maximum
Sep 21 2021
95.81M
Average
99.28M
Median
Market Cap Benchmarks
| Cyclacel Pharmaceuticals Inc | 3.810M |
| Arbutus Biopharma Corp | 487.37M |
| Oragenics Inc | 4.794M |
| Relmada Therapeutics Inc | 113.45M |
| MAIA Biotechnology Inc | 64.42M |
Market Cap Related Metrics
| Price to Book Value | 2.193 |
| Price | 1.73 |
| Earnings Yield | -32.37% |